Volume 15, Number 7—July 2009
Spread of Cantagalo Virus to Northern Brazil
Highlight and copy the desired format.
|EID||Medaglia ML, Pessoa LC, Sales ER, Freitas TR, Damaso CR. Spread of Cantagalo Virus to Northern Brazil. Emerg Infect Dis. 2009;15(7):1142-1143. https://dx.doi.org/10.3201/eid1507.081702|
|AMA||Medaglia ML, Pessoa LC, Sales ER, et al. Spread of Cantagalo Virus to Northern Brazil. Emerging Infectious Diseases. 2009;15(7):1142-1143. doi:10.3201/eid1507.081702.|
|APA||Medaglia, M. L., Pessoa, L. C., Sales, E. R., Freitas, T. R., & Damaso, C. R. (2009). Spread of Cantagalo Virus to Northern Brazil. Emerging Infectious Diseases, 15(7), 1142-1143. https://dx.doi.org/10.3201/eid1507.081702.|
To the Editor: Cantagalo virus (CTGV) is a strain of vaccinia virus (VACV; Poxviridae) that was isolated from pustular lesions on dairy cattle and dairy workers in Rio de Janeiro State, Brazil, in 1999 (1). Subsequently, similar lesions caused by poxviruses have been reported in cattle and humans in all 4 states of the southeast region of Brazil and in Goiás State in central-western Brazil (Technical Appendix [PDF - 751 KB - 2 pages], panel A, (2–7). Etiologic agents were VACV strains, most of which were genetically related to CTGV, such as Araçatuba and Passatempo viruses (2,4), with the exception of Guarani P1 virus, which was isolated in Minas Gerais State in 2001 and is phylogenetically close to VACV strain WR (5). Reisolation of Guarani P1 virus has not been reported. All VACV isolates related to CTGV share 2 molecular signatures: an 18-nt deletion in the A56R gene, which encodes viral hemagglutinin (1–7), and a 15-nt deletion in K2L gene, which encodes serine protease inhibitor-3 (8,9). Other VACV strains unrelated to CTGV were isolated from rodents in Brazil before 1999, but reisolation of these viruses has not been described (8). Although CTGV-like disease has not been reported in the northern, northeastern, and southern regions of the country, rapid interstate spread of CTGV infection is of concern. We report an episode of CTGV infection in Tocantins State, northern Brazil (Technical Appendix [PDF - 751 KB - 2 pages], panel A).
In September 2008, teat and udder lesions were found on 15 of 356 febrile (39.5°C–40°C) cattle on a dairy farm in the municipality of Muricilândia. Small papules progressed to vesicles and pustules (Technical Appendix [PDF - 751 KB - 2 pages], panel B), which usually healed in 3–4 weeks. New lesions subsequently appeared on previously healthy cows on the same farm, and muzzle lesions developed on suckling calves. Dairy workers reported fever and lesions on their hands and neck. The farm was quarantined for 3 weeks until the condition was diagnosed.
Four scab samples were sent for virus identification by PCR. Parts of the samples were used to infect BSC-40 cells and for DNA isolation by phenol-chloroform extraction, as described (6). After 48 hours, a strong cytopathic effect suggested poxvirus infection. The PCR used unambiguously differentiates CTGV-related infections from other orthopoxvirus diseases, including cowpox virus and several VACV strains (6). The reverse primer targets nucleotide sequences flanking the deletion signature of the hemagglutinin gene from CTGV-related viruses. Therefore, a specific annealing site for the reverse primer is produced when these external sequences are contiguous, as occurs in CTGV (6).
The full-length hemagglutinin gene (≈900 bp) was detected in all clinical isolates and in the control DNA samples from CTGV, VACV strain WR, and cowpox virus strain Brighton-red (Technical Appendix [PDF - 751 KB - 2 pages], panel C). Nevertheless, when we used the primers specific for CTGV detection, only CTGV and the 4 isolates were positive, generating 714-bp fragments, which indicated CTGV as the etiologic agent. In late November, the disease was reported in 9 cattle in Santa Fé do Araguaia, a municipality 12 km west of Muricilândia. Those samples were also positive for CTGV by PCR (data not shown).
For phylogenetic inference, we used DNA from the isolate MU-07 to sequence the genes A56R (927 bp), C7L (453 bp) that encodes a host-range virulence factor, and K2L (1095 bp); primers aligned externally to the open reading frames. PCR and sequencing were performed as described elsewhere (1). Sequences were deposited in GenBank (accession nos. FJ545689, FJ545688, and FJ545687, respectively). Nucleotide identities in relation to CTGV sequences were 99.8% (A56R), 100% (C7L), and 100% (K2L). Both A56R and K2L genes had deletions considered to be molecular signatures for Brazilian VACV related to CTGV. Phylogenetic inference of the concatenated nucleotide dataset of 27 orthopoxviruses shows that the causative agent grouped with other Brazilian VACV related to CTGV (Technical Appendix [PDF - 751 KB - 2 pages], panel D).
We consider the etiologic agent of the infection in Tocantins State to be a CTGV isolate, indicating spread of CTGV infection to northern Brazil. This spread could reflect interstate propagation of the virus due to movement of animals or people, which is particularly intense at the southern border with Goiás State (location of the nearest CTGV outbreak) (3). Nevertheless, no epidemiologic data are available to support a relationship between these episodes. The Agency for Animal Health Defense of Tocantins State has not been previously notified of clinical suspicion of poxvirus infection in dairy herds.
Another concern is spread of the virus to water buffalo, which account for a growing farming industry in Brazil, specifically in the northern states (www.ibge.gov.br/english). Infected buffalo have not yet been reported in Brazil, but the establishment of VACV strains in buffaloes has long been reported in India; economic losses have been substantial (9). Therefore, a careful survey should be conducted to evaluate dissemination of the virus to other states and species in the Amazon region.
We thank Marcia Helena da Fonseca, Mary Jane N. Abreu, and other staff of Agência de Defesa Agropecuária do Estado do Tocantins for their valuable support.
This work was supported by grants from the Conselho Nacional de Desenvolvimento Científico e Tecnólogico, Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro, and International Foundation for Sciences to C.D.; M.L.G.M. received a fellowship from PIBIC-Universidade Federal do Rio de Janeiro.
- Damaso CRA, Esposito JJ, Condit RC, Moussatché N. An emergent poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from Brazilian smallpox vaccine. Virology. 2000;277:439–49.
- de Souza Trindade G, da Fonseca FG, Marques JT, Nogueira ML, Mendes LC, Borges AS, Araçatuba virus: a vaccinialike virus associated with infection in humans and cattle. Emerg Infect Dis. 2003;9:155–60.
- Nagasse-Sugahara TK, Kisieliu JJ, Ueda-Ito M, Curti SP, Figueiredo CA, Cruz AS, Human vaccinia-like virus outbreaks in São Paulo and Goiás states, Brazil: virus detection, isolation and identification. Rev Inst Med Trop Sao Paulo. 2004;46:315–22.
- Leite JA, Drumond BT, Trindade GS, Lobato ZIP, da Fonseca FG, dos Santos JR, Passatempo virus, a vaccinia virus strain, Brazil. Emerg Infect Dis. 2005;12:1935–8.
- Trindade GS, Lobato ZIP, Drumond BP, Leite JA, Trigueiro RC, Guedes MIMC, Isolation of two vaccinia virus strains from a single bovine vaccinia outbreak in rural area from Brazil: implications on the emergence of zoonotic orthopoxviruses. Am J Trop Med Hyg. 2006;75:486–90.
- Damaso CR, Reis SA, Jesus DM, Lima PS, Moussatché N. A PCR-based assay for detection of emerging vaccinia-like viruses isolated in Brazil. Diagn Microbiol Infect Dis. 2007;57:39–46.
- Megid J, Appolinário CM, Langoni H, Pituco EM, Okuda LH. Vaccinia virus in humans and cattle in southwest region of São Paulo State, Brazil. Am J Trop Med Hyg. 2008;79:647–51.
- Drumond BP, Leite JA, da Fonseca FG, Bonjardim CA, Ferreira PC, Kroon EG. Brazilian vaccinia virus strains are genetically divergent and differ from the Lister vaccine strain. Microbes Infect. 2008;10:185–97.
- Moussatché N, Damaso CR, McFadden G. When good vaccines go wild: feral orthopoxvirus in developing countries and beyond. The Journal of Infection in Developing Countries. 2008;2:156–73.
Technical AppendixCite This Article
Please use the form below to submit correspondence to the authors or contact them at the following address:
Clarissa R. Damaso, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373 – CCS, Ilha do Fundão, 21941-590, Rio de Janeiro, RJ, Brazil
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: November 09, 2010
- Page last updated: November 09, 2010
- Page last reviewed: November 09, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)